Actionable news
0
All posts from Actionable news
Actionable news in GBSN: GREAT BASIN SCIENTIFIC INC,

Great Basin Initiates Clinical Trial For Bordatella Direct Test

SALT LAKE CITY--(BUSINESS WIRE)--

Great Basin Scientific, Inc. (GBSN), a molecular diagnostics company, today announced it has initiated a clinical trial for its sample-to-result Bordatella Direct Test, which will detect, directly from patient specimen, Bordatella pertussis, a bacteriumcausing a highly contagious respiratory disease commonly known as whooping cough. This is the first of five clinical trials the Company plans to initiate in 2016.

“As we’ve committed to our customers and stockholders, 2016 is going to be a time of continued R&D progress and customer growth for Great Basin,” said Ryan Ashton, co-founder and Chief Executive Officer of Great Basin Scientific. “The on-time start of the clinical trial for our Bordatella Direct Test is indicative of our commitment to delivering on our menu targets and represents Great Basin’s dedication to meeting strategic objectives.”

Great Basin intends to submit its 510(K) Clearance application for the Bordatella Direct Test...


More